EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Subcapsular Orchiectomy in the Primary Therapy of Patients with Bone Metastasis in Advanced Prostate Cancer: An Anachronistic Intervention?

Oleg Rud, Julia Peter, Reza Kheyri, Christian Gilfrich, Ali M Ahmed, Wieland Boeckmann, Paul G Fabricius, Matthias May

Advances in Urology · 2012 · 2012 · 1-5

DOI: 10.1155/2012/190624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Urology, 2012. Verfasst von Oleg Rud und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, St. Elisabeth Klinikum Straubing, St. Elisabeth Straße 23, 94315 Straubing, Germany. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The therapeutic impact of palliative androgen deprivation in metastatic prostate cancer is indisputable. Bilateral orchiectomy represents the traditional method of AD but was reduced during the last years in favor for treatment with LHRH analogues. Due to limited economic resources of the health care system, the economically priced definite surgical castration might experience a renaissance.

Methods

In this single-center retrospective study, 83 consecutive patients with osseous metastasized prostate cancer were evaluated, who had primarily been treated by subcapsular bilateral orchiectomy. Response to therapy, time until therapy failure, overall survival time, psychological disorders due to loss of organ, and disease-associated and postoperative surgical complications were recorded. The median followup was 35 months (IQR: 26–46).

Results

Patients' mean age at surgery was 72.1 (54–91) years. Six patients (7.2%) displayed immediate tumor progression after orchiectomy. Median time of tumor remission and overall survival time were 29 and 36 months, respectively. 14% of the study group showed minor postoperative complications. No psychological problems occurred following bilateral orchiectomy.

Conclusion

Due to an effective and persistent oncological effectiveness, less morbidity, and absence of psychological implications, bilateral subcapsular orchiectomy seems to be a practicable and advisable alternative in the first-line therapy of metastasized PCa.

Autor:innen und Institutionen

  • Department of Urology, St. Elisabeth Klinikum Straubing, St. Elisabeth Straße 23, 94315 Straubing, Germany.

Zitieren

APA

Rud, O., Peter, J., Kheyri, R., Gilfrich, C., Ahmed, A. M., Boeckmann, W., Fabricius, P. G., & May, M. (2012). Subcapsular Orchiectomy in the Primary Therapy of Patients with Bone Metastasis in Advanced Prostate Cancer: An Anachronistic Intervention?. Advances in Urology, 2012, 1-5. https://doi.org/10.1155/2012/190624

Vancouver

Rud O, Peter J, Kheyri R, Gilfrich C, Ahmed AM, Boeckmann W, et al. Subcapsular Orchiectomy in the Primary Therapy of Patients with Bone Metastasis in Advanced Prostate Cancer: An Anachronistic Intervention?. Advances in Urology. 2012;2012:1-5. doi:10.1155/2012/190624

BibTeX
@article{Rud2012,
  author = {Rud, Oleg and Peter, Julia and Kheyri, Reza and Gilfrich, Christian and Ahmed, Ali M and Boeckmann, Wieland and Fabricius, Paul G and May, Matthias},
  title = {Subcapsular Orchiectomy in the Primary Therapy of Patients with Bone Metastasis in Advanced Prostate Cancer: An Anachronistic Intervention?},
  journal = {Advances in Urology},
  year = {2012},
  volume = {2012},
  pages = {1--5},
  doi = {10.1155/2012/190624}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche